Particularly for breast cancer, a proteomics-based study revealed the lowest expression of GPD1 protein in triple-negative breast cancer (TNBC), suggesting a possible relationship between GPD1 and hormone receptors in breast cancer134. Here, GPD1 is linked to triple-negative breast carcinoma.